Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Glycosyltransferases (1)
- Donors used by glycosyltransferases (1)
- Donors used by glycosyltransferases (2)
- Nucleotide donors
- Lipid donors for glycosyltransferases
- Acceptors used by glycosyltransferases
- Glycosyltransferase reactions
- Typical mammalian cell surface oligosaccharides
- Diversity of sugars (1)
- Diversity of sugars (2)
- Diversity of sugars (3)
- Blood group A and B structures
- Glycosyltransferases (2)
- Structural folds for nucleotide glycosyltransferases
- Model enzymes for glycosyltransferases
- History of blood group ABO (1)
- History of blood group ABO (2)
- History of blood group ABO (3)
- History of blood group ABO (4)
- History of blood group ABO (5)
- Glycosyltransferases GTA/GTB
- Blood group biochemistry and genetics
- Transmembrane structure and cloning
- Expression and crystallography trials
- GTA and GTB crystals
- GTA and GTB structure
- Findings from 2002
- 3-deoxy-gal inhibitor
- Ordering of previously disordered structures
- Enzyme structure at substrate binding
- Inhibitors: interference with loop closure
- Electron density for intact donor at active site
- Excellent agreement with NMR conformation
- Comparison with other glycosyltransferases
- Recognition of UDP-gal by GTB: deoxy mapping
- Conclusions so far
- Mechanistic insights (1)
- What is the basis for donor specificity
- Only 2 of 4 critical residues in binding site (1)
- Only 2 of 4 critical residues in binding site (2)
- Which amino acid determines donor specificity?
- Mechanistic insights (2)
- Natural mutants identified in blood banks
- 11 of 200 mutations in blood bank screens
- P156L mutants: GTB no effect on kinetics
- P156L mutants: GTA activity reduced by half
- R176G BAAA: "super A" 4 X increase
- Single point mutation P234S
- M214R GTB near DXD metal binding motif
- Ten new mutations/new hot spots?
- Insights from natural mutants
- Acknowledgements
- Collaborations
Topics Covered
- Reactions catalyzed by glycosyltransferases: substrates and products
- Glycosyltransferase structural folds
- History of Blood group A and B enzymes as models for glycosyltransferase structures and mechanisms
- Properties of natural and unnatural blood group A and B glycosyltransferase mutants
Talk Citation
Palcic, M. (2012, November 27). Glycosyltransferases: structures and mechanisms [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 27, 2024, from https://doi.org/10.69645/MYLU7116.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Monica Palcic has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.